PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
31556760-5	2019	The patient was treated with topical dorzolamide and showed significant improvement in the degree of macular cysts.Conclusion: Mutations in KIZ can present with a predominantly macular phenotype and develop cystoid macular changes responsive to carbonic anhydrase inhibitor treatment.	dorzolamide	37-48	kizuna centrosomal protein	Homo sapiens	140-143
33000253-7	2020	Functional analyses demonstrated that a miR-653 inhibitor promoted short hairpin PLK1S1-attenuated cell proliferation, invasion and sorafenib resistance of RCC cells.	Sorafenib	132-141	kizuna centrosomal protein	Homo sapiens	81-87
33000253-11	2020	In conclusion, the present study revealed that PLK1S1 promoted tumor progression and sorafenib resistance in RCC through regulation of the miR-653/CXCR5 axis, which may offer a novel treatment strategy for patients with RCC.	Sorafenib	85-94	kizuna centrosomal protein	Homo sapiens	47-53